Finance

Lists
OPCH:NASDAQ
Option Care Health Inc
$31.65
0.00%
(0.00) 1D
Nov 10, 4:00:00โ€ฏPM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPCH...
Mkt. cap
4.74B
Avg. vol.
6.24M
Volume
10.00
P/E ratio
22.84
52-wk high
$36.80
52-wk low
$18.01
EPS
$1.39
Beta
0.47
Shares outstanding
149.80M
No. of employees
7K
Mkt. cap
4.74B
Avg. vol.
6.24M
Volume
10.00
P/E ratio
22.84
52-wk high
$36.80
52-wk low
$18.01
EPS
$1.39
Beta
0.47
Shares outstanding
149.80M
No. of employees
7K
News stories
From web sources and news partners
About Option Care Health Inc
CEO-
Employees7.4K
Founded1996
HeadquartersBannockburn, Illinois, United States
SectorHealth Care
IndustryHealth care provider
Websiteoptioncarehealth.com
Analyst ratings
Based on 7 analysts giving stock ratings to OPCH in the past 3 months
Buy
Buy
2
Hold
5
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for OPCH in the last 3 months.
Highest
Current $31.65
$33.00 (+4.27%)
Average
$32.29 (+2.02%)
Lowest
$32.05 (+1.26%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Hold
Maintained
-
-
11/04/2026
Erin Wright
Morgan Stanley
Hold
Downgraded
$32.05
+1.3%
10/12/2026
Lisa Gill
J.P. Morgan
Hold
Downgraded
$33.00
+4.3%
10/10/2026
A.J. Rice
UBS
Hold
Downgraded
$32.05
+1.3%
10/08/2026
Brian Tanquilut
Jefferies
Hold
Downgraded
$32.05
+1.3%
10/06/2026
David S Macdonald
Truist Financial
Buy
Maintained
-
-
10/06/2026
Matt Larew
William Blair
Buy
Maintained
-
-
10/06/2026
Charles Rhyee
TD Cowen
Hold
Maintained
$23.00
-27.3%
08/02/2026
Joanna Gajuk
Bank of America Securities
Hold
Reiterated
$25.00
-21%
07/29/2026
Pito Chickering
Deutsche Bank
Hold
Downgraded
$24.00
-24.2%
07/30/2026
Kyle Evans
Stephens
Hold
Downgraded
$24.00
-24.2%
07/17/2026
Raj Kumar CFA
Stephens
Hold
Downgraded
$24.00
-24.2%
07/17/2026
Scott Fidel
Goldman Sachs
Hold
Initiated
$22.00
-30.5%
06/08/2026
Constantine Davides
Citizens JMP
Buy
Maintained
$32.00
+1.1%
04/30/2026
Unknown Analyst
Jefferies
Buy
Maintained
$43.00
+35.9%
03/25/2026
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$0.49 / $0.49
+0.59%beat
Revenue / Est. (USD)
1.49B / 1.48B
+1.16%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.47B
1.35B
1.44B
1.49B
Cost of goods sold
1.18B
1.09B
1.18B
1.21B
Cost of revenue
1.18B
1.09B
1.18B
1.21B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
172.14M
174.56M
164.66M
177.64M
Operating expense
191.40M
189.47M
182.11M
195.76M
Total operating expenses
1.37B
1.28B
1.36B
1.40B
Operating income
91.50M
72.54M
85.14M
89.22M
Other non operating income
-6.00M
1.78M
-532.00K
2.78M
EBT including unusual items
81.52M
61.00M
73.99M
78.90M
EBT excluding unusual items
81.52M
61.00M
73.99M
78.90M
Income tax expense
23.01M
15.66M
20.07M
21.47M
Effective tax rate
28.23%
25.67%
27.13%
27.21%
Other operating expenses
-
-
-
-
Net income
58.50M
45.34M
53.91M
57.43M
Net profit margin
3.99%
3.36%
3.74%
3.85%
Earnings per share
0.46
0.40
0.45
0.49
Interest and investment income
-
-
-
-
Interest expense
-6.09M
-15.01M
-12.32M
-14.62M
Net interest expenses
-6.09M
-15.01M
-12.32M
-14.62M
Depreciation and amortization charges
19.26M
14.91M
17.45M
18.12M
EBITDA
111.82M
88.20M
103.52M
108.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps